Your browser doesn't support javascript.
loading
Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia.
Schafranek, L; Nievergall, E; Powell, J A; Hiwase, D K; Leclercq, T; Hughes, T P; White, D L.
Afiliação
  • Schafranek L; 1] Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia [2] Centre for Personalised Cancer Medicine (CPCM), Faculty of Health Science, University of Adelaide, Adelaide, South Australia, Australia [3] School of Medicine, University of Ade
  • Nievergall E; 1] Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia [2] Centre for Personalised Cancer Medicine (CPCM), Faculty of Health Science, University of Adelaide, Adelaide, South Australia, Australia [3] School of Medicine, University of Ade
  • Powell JA; 1] Discipline of Paediatrics, Faculty of Health Science, University of Adelaide, Adelaide, South Australia, Australia [2] Department of Immunology, SA Pathology, Adelaide, South Australia, Australia.
  • Hiwase DK; 1] School of Medicine, University of Adelaide, Adelaide, South Australia, Australia [2] Department of Haematology, SA Pathology, Adelaide, South Australia, Australia.
  • Leclercq T; 1] Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia [2] School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
  • Hughes TP; 1] Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia [2] Centre for Personalised Cancer Medicine (CPCM), Faculty of Health Science, University of Adelaide, Adelaide, South Australia, Australia [3] School of Medicine, University of Ade
  • White DL; 1] Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia [2] Centre for Personalised Cancer Medicine (CPCM), Faculty of Health Science, University of Adelaide, Adelaide, South Australia, Australia [3] School of Medicine, University of Ade
Leukemia ; 29(1): 76-85, 2015 Jan.
Article em En | MEDLINE | ID: mdl-24813920
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Apoptose / Inibidores de Proteínas Quinases / Fator de Transcrição STAT5 / Janus Quinase 2 Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Apoptose / Inibidores de Proteínas Quinases / Fator de Transcrição STAT5 / Janus Quinase 2 Idioma: En Ano de publicação: 2015 Tipo de documento: Article